BIOFIL CHEM & PHARMA Stock Context for AI Screening

BIOFIL CHEM & PHARMA LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for BIOFIL CHEM & PHARMA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive BIOFILCHEM stock page

Price

₹34.24

1W return

-7.26%

1M return

+0.56%

3M return

+12.26%

6M return

+2.00%

1Y return

-29.52%

Market cap

₹55.72 cr

20.12

2.62

ROE

+14.98%

ROCE

+17.15%

RSI

54.34

Turnover

₹0.27 cr

Why it can matter in screens

Momentum: BIOFILCHEM is above 50DMA; RSI is 54.34.
Returns: 1D -0.38%, 1W -7.26%, 1M +0.56%, 3M +12.26%, 1Y -29.52%.
Trend levels: 52W high ₹54.44, 52W low ₹25.79, off high -37.11%.
Liquidity: latest turnover is ₹0.27 cr; volume vs 20D is +1.13%.
Valuation/profitability: PE 20.12, PB 2.62, ROE +14.98%, ROCE +17.15%.
Growth: 3Y sales CAGR +14.27%, 3Y profit CAGR -7.17%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2025-12-31	0.86 cr	0.17 cr	0.08 cr	0.05
2025-09-30	13.54 cr	0.18 cr	0.08 cr	0.05
2025-06-30	6.43 cr	2.84 cr	2.41 cr	1.48
2025-03-31	8.35 cr	0.34 cr	0.20 cr	nan
2024-12-31	14.20 cr	0.33 cr	0.16 cr	0.10
2024-09-30	2.41 cr	0.14 cr	n/a	0.01
2024-06-30	8.44 cr	0.34 cr	0.17 cr	0.10
2024-03-31	n/a	n/a	n/a	nan

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-03-31	33.40 cr	1.15 cr	0.56 cr	0.34
2024-03-31	40.04 cr	1.31 cr	0.71 cr	0.44
2023-03-31	30.04 cr	1.26 cr	0.56 cr	0.34
2022-03-31	22.38 cr	1.49 cr	0.70 cr	0.44
2021-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-09-30	55.36 cr	0.23 cr	0.02 cr	21.30 cr
2025-03-31	50.96 cr	0.13 cr	0.47 cr	18.78 cr
2025-03-31	50.96 cr	0.26 cr	0.47 cr	18.78 cr
2024-09-30	42.04 cr	0.16 cr	0.46 cr	18.40 cr
2024-03-31	47.08 cr	2.28 cr	0.44 cr	18.20 cr

Cash flow

Period	OCF	FCF	Cash change
2025-12-31	n/a	n/a	n/a
2025-09-30	n/a	n/a	n/a
2025-06-30	n/a	n/a	n/a
2025-03-31	-1.92 cr	-2.02 cr	n/a
2025-03-31	n/a	n/a	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+46.79%	+0.00%	+0.08%	+0.00%	+53.13%	+0.00%
2025-12-31	+46.79%	+0.00%	+0.08%	+0.00%	+53.13%	+0.00%
2025-09-30	+46.79%	+0.00%	+0.08%	+0.00%	+53.13%	+0.00%
2025-06-30	+46.82%	+0.00%	+0.08%	+0.00%	+53.10%	+0.00%
2025-03-31	+46.82%	+0.00%	+0.08%	+0.00%	+53.10%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	429,121.06 cr	40.824543	+15.06%	+7.26%
DIVISLAB	DIVI S LABORATORIES LTD	174,585.42 cr	68.707369	+17.81%	+0.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	147,849.87 cr	68.354079	+29.94%	+39.35%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	119,204.71 cr	64.295958	+23.21%	+21.70%
CIPLA	CIPLA LTD	111,088.72 cr	29.624450	+12.91%	-6.65%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	108,331.15 cr	21.874917	+20.44%	+16.21%
DRREDDY	DR. REDDY S LABORATORIES	105,181.70 cr	24.542479	+13.88%	+1.20%
LUPIN	LUPIN LIMITED	103,385.66 cr	22.341869	+29.22%	+15.72%

Try these prompts

Analyze BIOFIL CHEM & PHARMA with valuation, momentum and industry peers
Compare BIOFILCHEM with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.